首页 > 最新文献

Arterial Hypertension最新文献

英文 中文
Association between hypertension and insulin resistance in non-diabetic adult populations: a community-based study from the Iran 非糖尿病成年人高血压与胰岛素抵抗之间的关系:一项来自伊朗的社区研究
IF 0.7 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2020-11-12 DOI: 10.5603/AH.A2020.0020
Fatemeh Samiee-Rad, S. Oveisi, H. Javadi, A. Barikani, M. Sofiabadi
Backgrounds and Objectives: High blood pressure increases the probability of insulin resistance and hyperinsulinemia. Also, insulin resistance can be defined as a risk factor for hypertension. The present study was investigated the relationship between hypertension and insulin resistance in non-diabetic participants who referred to Qazvin Metabolic Diseases Center. Materials and Methods: In this cross sectional study 1103 participants (111 non diabetic with newly diagnosed hypertension and 992 normotensive subjects aged ≥20 years) were enrolled from September 2014 to April 2016 in Qazvin (Iran). Systolic and diastolic blood pressure, Insulin resistance, waist circumference, body mass index, triglycerides ,cholesterol, LDL-cholesterol, FBS were measured. Fasting triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C) was used as a surrogate of insulin resistance. Data were analyzed using SPSS software and P < 0.05 were assumed as significant level. Results: 10% of all participants had hypertension. TG/HDL-C was 3.78 ±3.28 in non-HTN and 5.76±5.35 in HTN participants, respectively(P < 0.001). The frequency of all cardio-metabolic risk factors (except HDL cholesterol level) was higher than others after adjusting of age and gender in hypertensive group(P < 0.001). Discussion: Based these results, essential hypertension is associated with a higher prevalence of hyperinsulinemia and insulin resistance in the non-diabetic community in Iran.
背景和目的:高血压增加胰岛素抵抗和高胰岛素血症的可能性。此外,胰岛素抵抗可以被定义为高血压的一个危险因素。本研究旨在探讨到卡兹文代谢疾病中心就诊的非糖尿病患者高血压与胰岛素抵抗的关系。材料与方法:在这项横断面研究中,从2014年9月至2016年4月在伊朗Qazvin招募了1103名参与者(111名非糖尿病合并新诊断的高血压患者和992名年龄≥20岁的正常受试者)。测量收缩压、舒张压、胰岛素抵抗、腰围、体重指数、甘油三酯、胆固醇、低密度脂蛋白胆固醇、FBS。空腹甘油三酯与高密度脂蛋白胆固醇比值(TG/HDL-C)作为胰岛素抵抗的替代指标。数据采用SPSS软件分析,以P < 0.05为显著水平。结果:10%的参与者患有高血压。TG/HDL-C在非HTN组为3.78±3.28,HTN组为5.76±5.35 (P < 0.001)。调整年龄和性别后,高血压组除HDL胆固醇水平外,其他心血管代谢危险因素出现频率均高于其他危险因素(P < 0.001)。讨论:基于这些结果,原发性高血压与伊朗非糖尿病社区高胰岛素血症和胰岛素抵抗的较高患病率相关。
{"title":"Association between hypertension and insulin resistance in non-diabetic adult populations: a community-based study from the Iran","authors":"Fatemeh Samiee-Rad, S. Oveisi, H. Javadi, A. Barikani, M. Sofiabadi","doi":"10.5603/AH.A2020.0020","DOIUrl":"https://doi.org/10.5603/AH.A2020.0020","url":null,"abstract":"Backgrounds and Objectives: High blood pressure increases the probability of insulin resistance and hyperinsulinemia. Also, insulin resistance can be defined as a risk factor for hypertension. The present study was investigated the relationship between hypertension and insulin resistance in non-diabetic participants who referred to Qazvin Metabolic Diseases Center. Materials and Methods: In this cross sectional study 1103 participants (111 non diabetic with newly diagnosed hypertension and 992 normotensive subjects aged ≥20 years) were enrolled from September 2014 to April 2016 in Qazvin (Iran). Systolic and diastolic blood pressure, Insulin resistance, waist circumference, body mass index, triglycerides ,cholesterol, LDL-cholesterol, FBS were measured. Fasting triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C) was used as a surrogate of insulin resistance. Data were analyzed using SPSS software and P < 0.05 were assumed as significant level. Results: 10% of all participants had hypertension. TG/HDL-C was 3.78 ±3.28 in non-HTN and 5.76±5.35 in HTN participants, respectively(P < 0.001). The frequency of all cardio-metabolic risk factors (except HDL cholesterol level) was higher than others after adjusting of age and gender in hypertensive group(P < 0.001). Discussion: Based these results, essential hypertension is associated with a higher prevalence of hyperinsulinemia and insulin resistance in the non-diabetic community in Iran.","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":"23 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2020-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84619367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Objective measurement of physical activity in a random sample of Saint-Petersburg inhabitants 圣彼得堡随机抽样居民身体活动的客观测量
IF 0.7 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2020-09-29 DOI: 10.5603/AH.A2020.0018
A. Orlov, O. Rotar, M. Vigl, A. Konradi, H. Boeing
Background: World Health Organization (WHO) experts listed physical inactivity in leading risk factors for global mortality. Current research shows that only objective measurement of physical activity may provide accurate information on this parameter. The aim of our study was to assess the 7-day physical activity monitoring using triaxial accelerometers in a random sample of Saint-Petersburg inhabitants. Material and methods: As a part of all-Russian epidemiology survey ESSE-RF there was involved random sampling of 1600 Saint-Petersburg inhabitants (25–65 years) stratified by age and sex. After that a random sub-population of 100 subjects was selected. All subjects filled in questionnaire regarding physical activity, occupation, education and nutrition. Anthropometry (weight, height with body-mass index calculation, waist circumference) was performed. Actigraph GT3X+ (Actigraph LLC, USA) accelerometer and physical activity diary were used in order to evaluate physical activity monitoring for 7 days. Adequate levels of physical activity (PA) were defined as more than 10 000 steps/day and at least 150 minutes/week of moderate and vigorous physical activity (MVPA) in bouts of 10 minutes or more. Results: 1/2 of subjects were physically active according to steps, and 1/3 according to MVPA time criteria. No gender, occupation or body composition differences were revealed in physically active and inactive subjects. Almost 50% of physically active subjects had balanced workweek-weekend PA profile, and the same criterion is true only for 13% of subjects in inactive group. In both groups the same peaks of MVPA were revealed — at 8.00–9.00 and 18.00–19.00, which are typical transportation time, but in active group these peaks were significantly higher. According to PA diaries, in most of cases physical inactivity was related to the usage of private or public transport. Conclusion: Triaxial PA-monitoring shows, that 40–60% of subjects were physically inactive, and 150-min MVPA goal can easily be achieved by only increasing walking time during transportation peaks. The physical inactivity was not determined by the type of occupation, sex or age, instead it was mainly influenced by the usage of cars in the morning and evening transportation time, rather than walking.
背景:世界卫生组织(WHO)专家将缺乏身体活动列为全球死亡的主要危险因素。目前的研究表明,只有对体力活动进行客观测量才能提供有关该参数的准确信息。我们研究的目的是评估在圣彼得堡居民随机抽样中使用三轴加速度计进行的7天身体活动监测。材料和方法:作为全俄流行病学调查ESSE-RF的一部分,按年龄和性别分层随机抽样了1600名圣彼得堡居民(25-65岁)。然后,随机选择100名受试者的亚群。所有受试者都填写了关于体育活动、职业、教育和营养的问卷。进行了人体测量(体重,身高,体质指数计算,腰围)。使用Actigraph GT3X+ (Actigraph LLC, USA)加速度计和身体活动日记来评估7天的身体活动监测。适当的身体活动水平(PA)被定义为超过10,000步/天和至少150分钟/周的中度和剧烈身体活动(MVPA),每次10分钟或更长时间。结果:1/2的受试者按步数进行体力活动,1/3的受试者按MVPA时间标准进行体力活动。运动和不运动的受试者没有性别、职业或身体成分的差异。近50%的体力活动者有平衡的工作-周末PA特征,而在体力活动者中只有13%的人有相同的标准。两组MVPA峰值均在8.00 ~ 9.00和18.00 ~ 19.00出现,均为典型的转运时间,但活性组MVPA峰值均显著增高。根据PA日记,在大多数情况下,缺乏身体活动与使用私人或公共交通工具有关。结论:三轴pa监测显示,40-60%的受试者身体活动不活跃,只需在交通高峰时增加步行时间即可轻松达到150 min MVPA目标。运动不足与职业类型、性别和年龄无关,主要受早晚交通时间使用汽车的影响,而不是步行。
{"title":"Objective measurement of physical activity in a random sample of Saint-Petersburg inhabitants","authors":"A. Orlov, O. Rotar, M. Vigl, A. Konradi, H. Boeing","doi":"10.5603/AH.A2020.0018","DOIUrl":"https://doi.org/10.5603/AH.A2020.0018","url":null,"abstract":"Background: World Health Organization (WHO) experts listed physical inactivity in leading risk factors for global mortality. Current research shows that only objective measurement of physical activity may provide accurate information on this parameter. The aim of our study was to assess the 7-day physical activity monitoring using triaxial accelerometers in a random sample of Saint-Petersburg inhabitants. Material and methods: As a part of all-Russian epidemiology survey ESSE-RF there was involved random sampling of 1600 Saint-Petersburg inhabitants (25–65 years) stratified by age and sex. After that a random sub-population of 100 subjects was selected. All subjects filled in questionnaire regarding physical activity, occupation, education and nutrition. Anthropometry (weight, height with body-mass index calculation, waist circumference) was performed. Actigraph GT3X+ (Actigraph LLC, USA) accelerometer and physical activity diary were used in order to evaluate physical activity monitoring for 7 days. Adequate levels of physical activity (PA) were defined as more than 10 000 steps/day and at least 150 minutes/week of moderate and vigorous physical activity (MVPA) in bouts of 10 minutes or more. Results: 1/2 of subjects were physically active according to steps, and 1/3 according to MVPA time criteria. No gender, occupation or body composition differences were revealed in physically active and inactive subjects. Almost 50% of physically active subjects had balanced workweek-weekend PA profile, and the same criterion is true only for 13% of subjects in inactive group. In both groups the same peaks of MVPA were revealed — at 8.00–9.00 and 18.00–19.00, which are typical transportation time, but in active group these peaks were significantly higher. According to PA diaries, in most of cases physical inactivity was related to the usage of private or public transport. Conclusion: Triaxial PA-monitoring shows, that 40–60% of subjects were physically inactive, and 150-min MVPA goal can easily be achieved by only increasing walking time during transportation peaks. The physical inactivity was not determined by the type of occupation, sex or age, instead it was mainly influenced by the usage of cars in the morning and evening transportation time, rather than walking.","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":"27 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2020-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78231890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severity of SARS-COV-2 infection and angiotensin converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis SARS-COV-2感染的严重程度与血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂:一项荟萃分析
IF 0.7 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2020-09-21 DOI: 10.5603/AH.A2020.0013
T. Oscanoa, X. Vidal, A. Carvajal, J. Amado, R. Romero-Ortuño
Background: The mechanism of entry of SARS-COV-2 into the human host cell is through the ACE2 receptor. During the pandemic, a hypothesis has been proposed that angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) could be risk factors for the development of severe SARS-COV-2 infection. The objective of the study was to conduct a meta-analysis of the association between ACEI or ARB use and SARS-COV-2 infection severity or mortality. Material and methods: We searched PubMed, EMBASE, Google scholar and the Cochrane Database of Systematic Reviews for observational studies published between December 2019 and August 4, 2020 Studies were included if they contained data on ACEI or ARB use and SARS-COV-2 infection severity or mortality. Effect statistics were pooled using random-effects models. The quality of included studies was assessed with the Newcastle–Ottawa Scale (NOS). Data on study design, study location, year of publication, number of participants, sex, age at baseline, outcome definition, exposure definition, effect estimates and 95% CIs were extracted. Results: Twenty-six studies (21 cohort studies and 5 case-control studies) were identified for inclusion, combining to a total sample of 361467 participants. Mean age was 61.48 (SD 8.26) years and 51.63 % were men. The mean NOS score of included studies was 7.85 (range: 7–9). Results suggested that ACEI or ARB use did not increase the risk of severe disease or mortality from SARS-COV-2 infection (OR = 0.88, 95% CI: 0.75–1.02, p > 0.05). Conclusions: At present, the evidence available does not support the hypothesis of increased SARS-COV-2 risk with ACEI or ARB drugs.
背景:SARS-COV-2进入人宿主细胞的机制是通过ACE2受体。在大流行期间,提出了一种假设,即血管紧张素转换酶抑制剂(ACEIs)和血管紧张素II受体阻滞剂(ARBs)可能是发展为严重SARS-COV-2感染的危险因素。该研究的目的是对ACEI或ARB使用与SARS-COV-2感染严重程度或死亡率之间的关系进行荟萃分析。材料和方法:我们检索了PubMed、EMBASE、Google scholar和Cochrane系统评价数据库,检索了2019年12月至2020年8月4日期间发表的观察性研究,如果这些研究包含ACEI或ARB使用和SARS-COV-2感染严重程度或死亡率的数据,则纳入研究。使用随机效应模型汇总效果统计数据。纳入研究的质量采用纽卡斯尔-渥太华量表(NOS)进行评估。提取有关研究设计、研究地点、发表年份、受试者人数、性别、基线年龄、结局定义、暴露定义、效果估计和95% ci的数据。结果:纳入26项研究(21项队列研究和5项病例对照研究),共纳入361467名受试者。平均年龄61.48岁(SD 8.26),男性占51.63%。纳入研究的NOS平均评分为7.85(范围7-9)。结果显示,使用ACEI或ARB不会增加SARS-COV-2感染的严重疾病或死亡风险(or = 0.88, 95% CI: 0.75 ~ 1.02, p > 0.05)。结论:目前,现有证据不支持ACEI或ARB药物增加SARS-COV-2风险的假设。
{"title":"Severity of SARS-COV-2 infection and angiotensin converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis","authors":"T. Oscanoa, X. Vidal, A. Carvajal, J. Amado, R. Romero-Ortuño","doi":"10.5603/AH.A2020.0013","DOIUrl":"https://doi.org/10.5603/AH.A2020.0013","url":null,"abstract":"Background: The mechanism of entry of SARS-COV-2 into the human host cell is through the ACE2 receptor. During the pandemic, a hypothesis has been proposed that angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) could be risk factors for the development of severe SARS-COV-2 infection. The objective of the study was to conduct a meta-analysis of the association between ACEI or ARB use and SARS-COV-2 infection severity or mortality. Material and methods: We searched PubMed, EMBASE, Google scholar and the Cochrane Database of Systematic Reviews for observational studies published between December 2019 and August 4, 2020 Studies were included if they contained data on ACEI or ARB use and SARS-COV-2 infection severity or mortality. Effect statistics were pooled using random-effects models. The quality of included studies was assessed with the Newcastle–Ottawa Scale (NOS). Data on study design, study location, year of publication, number of participants, sex, age at baseline, outcome definition, exposure definition, effect estimates and 95% CIs were extracted. Results: Twenty-six studies (21 cohort studies and 5 case-control studies) were identified for inclusion, combining to a total sample of 361467 participants. Mean age was 61.48 (SD 8.26) years and 51.63 % were men. The mean NOS score of included studies was 7.85 (range: 7–9). Results suggested that ACEI or ARB use did not increase the risk of severe disease or mortality from SARS-COV-2 infection (OR = 0.88, 95% CI: 0.75–1.02, p > 0.05). Conclusions: At present, the evidence available does not support the hypothesis of increased SARS-COV-2 risk with ACEI or ARB drugs.","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":"16 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2020-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82788295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Utility of Systematic Coronary Risk Evaluation (SCORE) system to predict coronary artery disease severity in low to moderate risk hypertensive patients undergoing elective coronary angiography 应用系统冠状动脉风险评估(SCORE)系统预测择期行冠状动脉造影的中低危高血压患者的冠状动脉疾病严重程度
IF 0.7 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2020-09-17 DOI: 10.5603/AH.A2020.0017
Mehmet Eyuboglu, Metin Karayakalı, Kayıhan Karaman, A. Arısoy, A. Çelik
Background: Coronary artery disease (CAD) is the leading cause of mortality in hypertensive patients. Systematic Coronary Risk Evaluation (SCORE) is the preferred scoring system to predict future fatal cardiovascular events in hypertensive patients. However, the relationship between SCORE and coronary atherosclerosis is not well described. We aimed to investigate whether SCORE has a relationship with CAD severity in hypertensive patients, even in the absence of high risk features. Material and methods: Four hundred and fifty-two hypertensive patients who underwent elective coronary angiography and defined as low or moderate risk according to SCORE were included into the study. Patients were divided into two groups. Patients with a SCORE < 1% were defined as low risk group, and patients with a SCORE ≥ 1% and < 5% were defined as moderate risk group. The groups were compared regarding CAD severity. Results: The frequency of stenotic CAD and multivessel disease, and mean SYNTAX score, were significantly higher in SCORE ≥ 1%, and 22 with a sensitivity of 75% and a specificity of 86.5% (AUC: 0.879, p 22. (OR: 1.817, p < 0.001). Conclusion: Our results suggest that SCORE is associated with CAD severity in hypertensive patients even in the absence of high risk features. The SCORE system may be useful in further risk stratification of hypertensive patients with moderate risk features and suspected CAD.
背景:冠状动脉疾病(CAD)是高血压患者死亡的主要原因。系统冠状动脉风险评价(SCORE)是预测高血压患者未来致死性心血管事件的首选评分系统。然而,SCORE与冠状动脉粥样硬化之间的关系尚未得到很好的描述。我们的目的是研究即使在没有高风险特征的情况下,高血压患者的SCORE是否与CAD严重程度有关。材料和方法:452例接受择期冠状动脉造影并根据SCORE定义为低或中度风险的高血压患者纳入研究。患者分为两组。评分< 1%定义为低危组,评分≥1%和< 5%定义为中危组。比较各组CAD的严重程度。结果:狭窄性CAD和多血管疾病的发生频率和SYNTAX平均评分在评分≥1%和22时显著增高,敏感性为75%,特异性为86.5% (AUC: 0.879, p 22)。(OR: 1.817, p < 0.001)。结论:我们的研究结果表明,即使在没有高危特征的高血压患者中,SCORE也与CAD严重程度相关。SCORE系统可能有助于对具有中度危险特征和疑似冠心病的高血压患者进行进一步的风险分层。
{"title":"Utility of Systematic Coronary Risk Evaluation (SCORE) system to predict coronary artery disease severity in low to moderate risk hypertensive patients undergoing elective coronary angiography","authors":"Mehmet Eyuboglu, Metin Karayakalı, Kayıhan Karaman, A. Arısoy, A. Çelik","doi":"10.5603/AH.A2020.0017","DOIUrl":"https://doi.org/10.5603/AH.A2020.0017","url":null,"abstract":"Background: Coronary artery disease (CAD) is the leading cause of mortality in hypertensive patients. Systematic Coronary Risk Evaluation (SCORE) is the preferred scoring system to predict future fatal cardiovascular events in hypertensive patients. However, the relationship between SCORE and coronary atherosclerosis is not well described. We aimed to investigate whether SCORE has a relationship with CAD severity in hypertensive patients, even in the absence of high risk features. Material and methods: Four hundred and fifty-two hypertensive patients who underwent elective coronary angiography and defined as low or moderate risk according to SCORE were included into the study. Patients were divided into two groups. Patients with a SCORE < 1% were defined as low risk group, and patients with a SCORE ≥ 1% and < 5% were defined as moderate risk group. The groups were compared regarding CAD severity. Results: The frequency of stenotic CAD and multivessel disease, and mean SYNTAX score, were significantly higher in SCORE ≥ 1%, and 22 with a sensitivity of 75% and a specificity of 86.5% (AUC: 0.879, p 22. (OR: 1.817, p < 0.001). Conclusion: Our results suggest that SCORE is associated with CAD severity in hypertensive patients even in the absence of high risk features. The SCORE system may be useful in further risk stratification of hypertensive patients with moderate risk features and suspected CAD.","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":"26 1","pages":"128-134"},"PeriodicalIF":0.7,"publicationDate":"2020-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84118586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Cardiovascular diseases in youth patients with glucose metabolism impairment 青年糖代谢障碍患者的心血管疾病
IF 0.7 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2020-09-16 DOI: 10.5603/AH.A2020.0016
A. Pilśniak, A. Chwalba, E. Otto-Buczkowska
Glucose metabolism disorders in adolescent patients have a diverse background. The most common cause is Type 1 diabetes. Persistently elevated blood glucose initiates many processes that lead to blood vessel and nerve damage. Early detection and treatment of these abnormalities can help prevent the development of many complications.
青少年患者的糖代谢紊乱有不同的背景。最常见的原因是1型糖尿病。持续升高的血糖会引发许多导致血管和神经损伤的过程。早期发现和治疗这些异常有助于预防许多并发症的发生。
{"title":"Cardiovascular diseases in youth patients with glucose metabolism impairment","authors":"A. Pilśniak, A. Chwalba, E. Otto-Buczkowska","doi":"10.5603/AH.A2020.0016","DOIUrl":"https://doi.org/10.5603/AH.A2020.0016","url":null,"abstract":"Glucose metabolism disorders in adolescent patients have a diverse background. The most common cause is Type 1 diabetes. Persistently elevated blood glucose initiates many processes that lead to blood vessel and nerve damage. Early detection and treatment of these abnormalities can help prevent the development of many complications.","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":"27 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2020-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83549715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum amphiregulin and cerebellin 1 levels in primary hypertension patients 原发性高血压患者血清双调节蛋白和小脑蛋白1水平的变化
IF 0.7 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2020-09-16 DOI: 10.5603/AH.A2020.0015
Ö. Güler, Hakan Hakkoymaz, S. Köroğlu, Muhammed Seyithanoğlu, Hakan Güneş
Background: Hypertension is a major risk factor for cardiovascular diseases, stroke, congestive heart disease and renal failure. Primary hypertension is a multi-factorial complex disease and its exact etiology still remains unknown. In this study we aimed to compare serum amphiregulin and cerebellin-1 levels of primary hypertension patients with healthy subjects. Material and methods: Forty-four hypertensive patients and 44 healthy people were included. Patients with systolic blood pressure measurements ≥ 140 mm Hg and diastolic blood pressure measurements ≥ 90 mm Hg were evaluated as hypertensive. Serum amphiregulin and cerebellin 1 levels were measured using ELISA method. Results: Mean amphiregulin level was 32.1 (10.2–72.5) pg/mL in hypertension group and 36.9 (15.9–109.5) pg/mL in control group (p = 0.002). Mean cerebellin 1 levels were comparable in both groups, 82.1 (23.9–286.1) pg/mL in hypertensive group and 95.1 (60.2–293) pg/mL in control group (p = 0.261). Serum amphiregulin to predict hypertension was found to be ≤ 23 pg/mL with specificity of 97% and sensitivity of 48.5% (AUC = 0.74; 95% CI, 0.62–0.86; p = 0.001). Conclusions: Hypertension is associated with lower serum amphiregulin concentrations.
背景:高血压是心血管疾病、中风、充血性心脏病和肾衰竭的主要危险因素。原发性高血压是一种多因素的复杂疾病,其确切病因尚不清楚。在本研究中,我们旨在比较原发性高血压患者与健康人血清双调节蛋白和小脑素-1的水平。材料与方法:选取44例高血压患者和44例正常人。收缩压≥140 mm Hg和舒张压≥90 mm Hg的患者被评价为高血压。ELISA法测定血清双调节蛋白和小脑蛋白1水平。结果:高血压组双调节蛋白平均水平为32.1 (10.2 ~ 72.5)pg/mL,对照组平均水平为36.9 (15.9 ~ 109.5)pg/mL (p = 0.002)。两组平均小脑素1水平比较,高血压组为82.1 (23.9 ~ 286.1)pg/mL,对照组为95.1 (60.2 ~ 293)pg/mL (p = 0.261)。血清双调节蛋白预测高血压的指标≤23 pg/mL,特异性为97%,敏感性为48.5% (AUC = 0.74;95% ci, 0.62-0.86;P = 0.001)。结论:高血压与血清双调节蛋白浓度降低有关。
{"title":"Serum amphiregulin and cerebellin 1 levels in primary hypertension patients","authors":"Ö. Güler, Hakan Hakkoymaz, S. Köroğlu, Muhammed Seyithanoğlu, Hakan Güneş","doi":"10.5603/AH.A2020.0015","DOIUrl":"https://doi.org/10.5603/AH.A2020.0015","url":null,"abstract":"Background: Hypertension is a major risk factor for cardiovascular diseases, stroke, congestive heart disease and renal failure. Primary hypertension is a multi-factorial complex disease and its exact etiology still remains unknown. In this study we aimed to compare serum amphiregulin and cerebellin-1 levels of primary hypertension patients with healthy subjects. Material and methods: Forty-four hypertensive patients and 44 healthy people were included. Patients with systolic blood pressure measurements ≥ 140 mm Hg and diastolic blood pressure measurements ≥ 90 mm Hg were evaluated as hypertensive. Serum amphiregulin and cerebellin 1 levels were measured using ELISA method. Results: Mean amphiregulin level was 32.1 (10.2–72.5) pg/mL in hypertension group and 36.9 (15.9–109.5) pg/mL in control group (p = 0.002). Mean cerebellin 1 levels were comparable in both groups, 82.1 (23.9–286.1) pg/mL in hypertensive group and 95.1 (60.2–293) pg/mL in control group (p = 0.261). Serum amphiregulin to predict hypertension was found to be ≤ 23 pg/mL with specificity of 97% and sensitivity of 48.5% (AUC = 0.74; 95% CI, 0.62–0.86; p = 0.001). Conclusions: Hypertension is associated with lower serum amphiregulin concentrations.","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":"5 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2020-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78839190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between Hypertension and Insulin resistance in non-diabetic adult populations: a community-based study from the Center of Iran 非糖尿病成年人高血压与胰岛素抵抗之间的关系:来自伊朗中心的一项社区研究
IF 0.7 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2020-09-15 DOI: 10.5603/AH.A2020.0014
M. Sofiabadi
Backgrounds and Objectives: High blood pressure increases the probability of insulin resistance and hyperinsulinemia. Also, insulin resistance can be defined as a risk factor for hypertension. The present study was investigated the relationship between hypertension and insulin resistance in non-diabetic participants who referred to Qazvin Metabolic Diseases Center. Materials and Methods: In this cross sectional study 1103 participants (111 non diabetic with newly diagnosed hypertension and 992 normotensive subjects aged ≥20 years) were enrolled from September 2014 to April 2016 in Qazvin (Iran). Systolic and diastolic blood pressure, Insulin resistance, waist circumference, body mass index, triglycerides ,cholesterol, LDL-cholesterol, FBS were measured. Fasting triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C) was used as a surrogate of insulin resistance. Data were analyzed using SPSS software and P < 0.05 were assumed as significant level. Results: 10% of all participants had hypertension. TG/HDL-C was 3.78 ±3.28 in non-HTN and 5.76±5.35 in HTN participants, respectively(P < 0.001). The frequency of all cardio-metabolic risk factors (except HDL cholesterol level) was higher than others after adjusting of age and gender in hypertensive group(P < 0.001). Conclusion: Based these results, essential hypertension is associated with a higher prevalence of hyperinsulinemia and insulin resistance in the non-diabetic community in Iran.
背景和目的:高血压增加胰岛素抵抗和高胰岛素血症的可能性。此外,胰岛素抵抗可以被定义为高血压的一个危险因素。本研究旨在探讨到卡兹文代谢疾病中心就诊的非糖尿病患者高血压与胰岛素抵抗的关系。材料与方法:在这项横断面研究中,从2014年9月至2016年4月在伊朗Qazvin招募了1103名参与者(111名非糖尿病合并新诊断的高血压患者和992名年龄≥20岁的正常受试者)。测量收缩压、舒张压、胰岛素抵抗、腰围、体重指数、甘油三酯、胆固醇、低密度脂蛋白胆固醇、FBS。空腹甘油三酯与高密度脂蛋白胆固醇比值(TG/HDL-C)作为胰岛素抵抗的替代指标。数据采用SPSS软件分析,以P < 0.05为显著水平。结果:10%的参与者患有高血压。TG/HDL-C在非HTN组为3.78±3.28,HTN组为5.76±5.35 (P < 0.001)。调整年龄和性别后,高血压组除HDL胆固醇水平外,其他心血管代谢危险因素出现频率均高于其他危险因素(P < 0.001)。结论:基于这些结果,原发性高血压与伊朗非糖尿病社区高胰岛素血症和胰岛素抵抗的较高患病率相关。
{"title":"Association between Hypertension and Insulin resistance in non-diabetic adult populations: a community-based study from the Center of Iran","authors":"M. Sofiabadi","doi":"10.5603/AH.A2020.0014","DOIUrl":"https://doi.org/10.5603/AH.A2020.0014","url":null,"abstract":"Backgrounds and Objectives: High blood pressure increases the probability of insulin resistance and hyperinsulinemia. Also, insulin resistance can be defined as a risk factor for hypertension. The present study was investigated the relationship between hypertension and insulin resistance in non-diabetic participants who referred to Qazvin Metabolic Diseases Center. Materials and Methods: In this cross sectional study 1103 participants (111 non diabetic with newly diagnosed hypertension and 992 normotensive subjects aged ≥20 years) were enrolled from September 2014 to April 2016 in Qazvin (Iran). Systolic and diastolic blood pressure, Insulin resistance, waist circumference, body mass index, triglycerides ,cholesterol, LDL-cholesterol, FBS were measured. Fasting triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C) was used as a surrogate of insulin resistance. Data were analyzed using SPSS software and P < 0.05 were assumed as significant level. Results: 10% of all participants had hypertension. TG/HDL-C was 3.78 ±3.28 in non-HTN and 5.76±5.35 in HTN participants, respectively(P < 0.001). The frequency of all cardio-metabolic risk factors (except HDL cholesterol level) was higher than others after adjusting of age and gender in hypertensive group(P < 0.001). Conclusion: Based these results, essential hypertension is associated with a higher prevalence of hyperinsulinemia and insulin resistance in the non-diabetic community in Iran.","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":"92 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2020-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76590598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Salt and arterial hypertension — epidemiological, pathophysiological and preventive aspects 盐与高血压的流行病学、病理生理和预防方面
IF 0.7 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2020-09-07 DOI: 10.5603/AH.A2020.0012
S. Surma, A. Szyndler, K. Narkiewicz
Arterial hypertension in majority of cases is the result of a poor lifestyle. The table salt intake level has changed over the centuries. In populations characterized by a low level of daily salt consumption, hypertension was a rarity and cardiovascular diseases were much less common. More and more food is sold in processed form, and thus containing large amounts of salt. The amount of salt delivered with food significantly exceeds the actual body's needs. Limitation of salt intake should apply to both prevention of hypertension and cardiovascular diseases as well as treatment of people suffering from hypertension. High sodium intake leads to increased systolic and diastolic pressure, increases the risk of cardiovascular disease as well as other diseases such as stomach cancer etc. There are many mechanisms triggered by excessive intake of table salt that lead to an increase in blood pressure. Excess salt adversely affects the entire human body, and in particular the kidneys and blood vessels. National and International Scientific Societies have developed many documents in the form of guidelines on the optimal daily sodium intake. Compliance with the recommendations and limitation of salt intake may significantly reduce the incidence of hypertension in the general population.
在大多数情况下,动脉高血压是不良生活方式的结果。几个世纪以来,食盐的摄入量一直在变化。在以每日盐摄入量低为特征的人群中,高血压很少见,心血管疾病也不常见。越来越多的食品以加工形式出售,因此含有大量的盐。食物中盐的含量远远超过了身体的实际需要。限制盐的摄入既适用于高血压和心血管疾病的预防,也适用于高血压患者的治疗。高钠摄入会导致收缩压和舒张压升高,增加心血管疾病以及胃癌等其他疾病的风险。过量摄入食盐导致血压升高的机制有很多。过量的盐会对整个人体产生不利影响,尤其是肾脏和血管。国家和国际科学协会已经制定了许多关于每日最佳钠摄入量指南的文件。遵守建议和限制盐的摄入可以显著降低普通人群的高血压发病率。
{"title":"Salt and arterial hypertension — epidemiological, pathophysiological and preventive aspects","authors":"S. Surma, A. Szyndler, K. Narkiewicz","doi":"10.5603/AH.A2020.0012","DOIUrl":"https://doi.org/10.5603/AH.A2020.0012","url":null,"abstract":"Arterial hypertension in majority of cases is the result of a poor lifestyle. The table salt intake level has changed over the centuries. In populations characterized by a low level of daily salt consumption, hypertension was a rarity and cardiovascular diseases were much less common. More and more food is sold in processed form, and thus containing large amounts of salt. The amount of salt delivered with food significantly exceeds the actual body's needs. Limitation of salt intake should apply to both prevention of hypertension and cardiovascular diseases as well as treatment of people suffering from hypertension. High sodium intake leads to increased systolic and diastolic pressure, increases the risk of cardiovascular disease as well as other diseases such as stomach cancer etc. There are many mechanisms triggered by excessive intake of table salt that lead to an increase in blood pressure. Excess salt adversely affects the entire human body, and in particular the kidneys and blood vessels. National and International Scientific Societies have developed many documents in the form of guidelines on the optimal daily sodium intake. Compliance with the recommendations and limitation of salt intake may significantly reduce the incidence of hypertension in the general population.","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":"35 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2020-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83753534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Lack of association between angiotensin-converting enzyme (ACE) genotype and essential hypertension in Peruvian older people 秘鲁老年人血管紧张素转换酶(ACE)基因型与原发性高血压之间缺乏关联
IF 0.7 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2020-09-07 DOI: 10.5603/AH.A2020.0011
T. Oscanoa, E. Cieza, F. Lizaraso-Soto, M. L. Guevara, R. Fujita, R. Romero-Ortuño
Background: Epidemiological studies have shown an association between the ACE gene I/D polymorphism with arterial hypertension, specifically the DD genotype, in different populations. The objective of this study is to evaluate the association between ACE polymorphisms (Insertion, Deletion or I/D) and essential hypertension in a population of Lima, Peru. Material and methods: This is a study of cases (essential arterial hypertension) and controls, with determination of the ACE I/D genotype. Results: Cases (65) and controls (39) had a mean age (standard deviation) of 74.3 (7.9) and 72.6 (6.5) (p = 0.24). In cases, the genotype frequencies DD, ID, and II were 6 (9.2%), 28 (43.1%) and 31 (47.7%), respectively. In controls, the genotype frequencies DD, ID, and II were 6 (15.4%), 14 (35.9%) and 19 (48.7%). The Hardy-Weinberg equilibrium analysis in cases and controls was p = 0.93 and p = 0.23, respectively. No significant associations between genotype DD vs. ID + II (OR = 0.56, 95% CI: 0.17–1.87, p = 0.34) or II vs. DD + ID (OR = 0.95, 95% CI: 0.43–2.12, p = 0.92) and essential hypertension were found. Conclusions: The ACE I/D polymorphism was not associated with hypertension in our sample.
背景:流行病学研究表明,不同人群中ACE基因I/D多态性与动脉性高血压,特别是DD基因型之间存在关联。本研究的目的是评估秘鲁利马人群中ACE多态性(插入、缺失或I/D)与原发性高血压之间的关系。材料和方法:这是一项病例(原发性动脉高血压)和对照组的研究,确定ACE I/D基因型。结果:病例(65)和对照组(39)的平均年龄(标准差)分别为74.3(7.9)和72.6(6.5),差异有统计学意义(p = 0.24)。DD、ID和II基因型频率分别为6(9.2%)、28(43.1%)和31(47.7%)。对照组DD、ID和II基因型频率分别为6(15.4%)、14(35.9%)和19(48.7%)。病例和对照组的Hardy-Weinberg平衡分析分别为p = 0.93和p = 0.23。基因型DD vs. ID + II (OR = 0.56, 95% CI: 0.17-1.87, p = 0.34)或基因型II vs. DD + ID (OR = 0.95, 95% CI: 0.43-2.12, p = 0.92)与原发性高血压无显著相关性。结论:在我们的样本中,ACE I/D多态性与高血压无关。
{"title":"Lack of association between angiotensin-converting enzyme (ACE) genotype and essential hypertension in Peruvian older people","authors":"T. Oscanoa, E. Cieza, F. Lizaraso-Soto, M. L. Guevara, R. Fujita, R. Romero-Ortuño","doi":"10.5603/AH.A2020.0011","DOIUrl":"https://doi.org/10.5603/AH.A2020.0011","url":null,"abstract":"Background: Epidemiological studies have shown an association between the ACE gene I/D polymorphism with arterial hypertension, specifically the DD genotype, in different populations. The objective of this study is to evaluate the association between ACE polymorphisms (Insertion, Deletion or I/D) and essential hypertension in a population of Lima, Peru. Material and methods: This is a study of cases (essential arterial hypertension) and controls, with determination of the ACE I/D genotype. Results: Cases (65) and controls (39) had a mean age (standard deviation) of 74.3 (7.9) and 72.6 (6.5) (p = 0.24). In cases, the genotype frequencies DD, ID, and II were 6 (9.2%), 28 (43.1%) and 31 (47.7%), respectively. In controls, the genotype frequencies DD, ID, and II were 6 (15.4%), 14 (35.9%) and 19 (48.7%). The Hardy-Weinberg equilibrium analysis in cases and controls was p = 0.93 and p = 0.23, respectively. No significant associations between genotype DD vs. ID + II (OR = 0.56, 95% CI: 0.17–1.87, p = 0.34) or II vs. DD + ID (OR = 0.95, 95% CI: 0.43–2.12, p = 0.92) and essential hypertension were found. Conclusions: The ACE I/D polymorphism was not associated with hypertension in our sample.","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":"53 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2020-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77458496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Effectiveness of telemedicine-guided home blood pressure compared to 24 h-ambulatory blood pressure monitoring in patients with and without chronic kidney disease. 远程医疗引导的家庭血压与24小时动态血压监测在慢性肾病患者和非慢性肾病患者中的有效性比较
IF 0.7 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2020-06-30 DOI: 10.5603/AH.A2020.0010
X. Galloo, T. Robberechts, P. Niepen
Background. Only few direct comparative studies evaluated the effectiveness of telemedicine-guided home blood pressure (tele-HBPM) compared to 24 h ambulatory blood pressure monitoring (ABPM) in assessing blood pressure (BP) and BP control. Material and methods. This prospective clinical trial included patients with arterial hypertension, with (n = 23) and without (n = 18) chronic kidney disease and normal volunteers (n = 16). All subjects underwent with a 1-month interval twice one-week of BP monitoring with office BP (3 measurements at 2 visits), 24 h-ABPM and tele-HBPM during 7 consecutive days. Results. Mean (SD) BP levels were 128/77 [19/11] mm Hg and 126/75 [14/9] mm Hg for tele-HBPM, 129/78 [17/11] mm Hg and 127/75 [14/9] mm Hg for daytime-ABPM, and 133/77 [23/12] mm Hg and 130/74 [17/11] mm Hg for office BP, all respectively at the first and the second measurement periods. Blood pressure and BP control were comparable between the two out-of-office techniques. Conclusion. Both out-of-office techniques (tele-HBPM and 24h-ABPM) show good agreement for systolic as well as diastolic BP, and are equally effective in assessing BP and BP control, explicitly during daytime.
背景。只有少数直接比较研究评估了远程医疗引导的家庭血压(远程hbpm)与24小时动态血压监测(ABPM)在评估血压(BP)和血压控制方面的有效性。材料和方法。这项前瞻性临床试验包括有动脉高血压、有慢性肾脏疾病(n = 23)和没有慢性肾脏疾病(n = 18)的患者以及正常志愿者(n = 16)。所有受试者均接受为期1个月的两次血压监测,包括办公室血压监测(2次就诊3次),连续7天进行24小时abpm和远程hbpm。结果。远程hbpm的平均血压(SD)水平分别为128/77 [19/11]mm Hg和126/75 [14/9]mm Hg,白天abpm的平均血压(SD)水平为129/78 [17/11]mm Hg和127/75 [14/9]mm Hg,办公室血压(SD)水平分别为133/77 [23/12]mm Hg和130/74 [17/11]mm Hg。两种非办公室技术的血压和血压控制是相当的。结论。两种非办公室技术(远程hbpm和24h-ABPM)对收缩压和舒张压都有很好的一致性,在评估血压和控制血压方面同样有效,特别是在白天。
{"title":"Effectiveness of telemedicine-guided home blood pressure compared to 24 h-ambulatory blood pressure monitoring in patients with and without chronic kidney disease.","authors":"X. Galloo, T. Robberechts, P. Niepen","doi":"10.5603/AH.A2020.0010","DOIUrl":"https://doi.org/10.5603/AH.A2020.0010","url":null,"abstract":"Background. Only few direct comparative studies evaluated the effectiveness of telemedicine-guided home blood pressure (tele-HBPM) compared to 24 h ambulatory blood pressure monitoring (ABPM) in assessing blood pressure (BP) and BP control. Material and methods. This prospective clinical trial included patients with arterial hypertension, with (n = 23) and without (n = 18) chronic kidney disease and normal volunteers (n = 16). All subjects underwent with a 1-month interval twice one-week of BP monitoring with office BP (3 measurements at 2 visits), 24 h-ABPM and tele-HBPM during 7 consecutive days. Results. Mean (SD) BP levels were 128/77 [19/11] mm Hg and 126/75 [14/9] mm Hg for tele-HBPM, 129/78 [17/11] mm Hg and 127/75 [14/9] mm Hg for daytime-ABPM, and 133/77 [23/12] mm Hg and 130/74 [17/11] mm Hg for office BP, all respectively at the first and the second measurement periods. Blood pressure and BP control were comparable between the two out-of-office techniques. Conclusion. Both out-of-office techniques (tele-HBPM and 24h-ABPM) show good agreement for systolic as well as diastolic BP, and are equally effective in assessing BP and BP control, explicitly during daytime.","PeriodicalId":42110,"journal":{"name":"Arterial Hypertension","volume":"72 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2020-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84341389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Arterial Hypertension
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1